International Stem Cell CORP (ISCO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1M 2M 3M Q3 '24: 2.2M Q4 '24: 2.4M Q1 '25: 2.1M Q2 '25: 2.4M Q3 '25: 2.4M Q4 '25: 2.2M Q1 '26: 2.3M Q2 '26: 2.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 600K 1.2M 1.8M Q3 '24: 1.2M Q4 '24: 1.5M Q1 '25: 1.1M Q2 '25: 1.5M Q3 '25: 1.3M Q4 '25: 1.1M Q1 '26: 1.4M Q2 '26: 1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '24: -90K Q4 '24: 51K Q1 '25: -215K Q2 '25: 167K Q3 '25: 94K Q4 '25: -313K Q1 '26: -190K Q2 '26: -35K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '24: -125K Q4 '24: 11K Q1 '25: -256K Q2 '25: 129K Q3 '25: 57K Q4 '25: -348K Q1 '26: -220K Q2 '26: -71K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 500K 1M 1.5M Q3 '24: 974K Q4 '24: 990K Q1 '25: 992K Q2 '25: 927K Q3 '25: 1M Q4 '25: 1.1M Q1 '26: 954K Q2 '26: 1.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '24: 257K Q4 '24: -74K Q1 '25: 227K Q2 '25: -300K Q3 '25: 49K Q4 '25: 32K Q1 '26: 121K Q2 '26: 167K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q3 '24: 220K Q4 '24: -75K Q1 '25: 222K Q2 '25: -332K Q3 '25: 46K Q4 '25: 29K Q1 '26: 98K Q2 '26: 160K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 3M 6M 9M Q1 '24: 8M Q2 '24: 8M Q3 '24: 8M Q1 '25: 8M Q2 '25: 8M Q3 '25: 8.2M Q1 '26: 8M Q2 '26: 8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.09 -0.06 -0.03 0.00 0.03 0.06 0.09 Q3 '24: -0.07 Q4 '24: -0.04 Q1 '25: -0.04 Q2 '25: -0.04 Q3 '25: -0.02 Q4 '25: -0.06 Q1 '26: -0.06 Q2 '26: -0.08 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.